Compliance certificate for dematerialization of securities for Q2 FY27

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.5%Reaction day

₹147.75

prior close

₹148.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+0.1% vs market

Pharmaceuticals peers, median of 170sector+0.9%+0.6% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.2

15m

-0.2

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.5+1.3+0.1+0.9+0.6

Next day

+2.9+1.1+1.8+0.8+2.0

+1.9-1.7+3.6-1.4+3.3

+3.6-1.5+5.1-1.4+5.0

+1.7-0.6+2.3-1.8+3.5

+0.2-0.4+0.6-2.0+2.2

+0.5-1.4+1.9-2.5+3.0

15d

-2.0-6.0+4.0-2.7+0.7

-2.7pendingpending-2.0-0.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kerala Ayurveda filed a compliance certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The certificate from Integrated Registry Management Services, the company's Registrar and Share Transfer Agent, confirms that securities received for dematerialization during the quarter were duly processed and that the underlying shares are listed on the stock exchange. This is a routine quarterly compliance filing.

Likely market impact

Routine quarterly regulatory compliance filing. No material impact on stock or shareholders.